Bal S, Htut M, Berdeja J, Anderson L, Rossi A, Gregory T, Costa L, Hu H, Guo Z, Chen J, Jordahl K, Sarkis N, Ziyad S, Kao W, Kaeding A, Burgess M, Nadeem O. P33 | ARLOCABTAGENE AUTOLEUCEL, A GPRC5D-TARGETED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1 SAFETY AND EFFICACY RESULTS IN PATIENTS WITH 1–3 PRIOR REGIMENS. haematol [Internet]. 2026Apr.15 [cited 2026Apr.21];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14112